234 related articles for article (PubMed ID: 27067440)
1. Age at First Rotavirus Vaccination and Risk of Intussusception in Infants: A Public Health Modeling Analysis.
Yung CF; Chong CY; Thoon KC
Drug Saf; 2016 Aug; 39(8):745-8. PubMed ID: 27067440
[TBL] [Abstract][Full Text] [Related]
2. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003-2012).
Costantino C; Restivo V; Cuccia M; Furnari R; Amodio E; Vitale F
Ital J Pediatr; 2015 Aug; 41():52. PubMed ID: 26232152
[TBL] [Abstract][Full Text] [Related]
4. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
[TBL] [Abstract][Full Text] [Related]
5. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America.
Desai R; Parashar UD; Lopman B; de Oliveira LH; Clark AD; Sanderson CF; Tate JE; Matus CR; Andrus JK; Patel MM
Clin Infect Dis; 2012 May; 54(10):1397-405. PubMed ID: 22431803
[TBL] [Abstract][Full Text] [Related]
6. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000-2009.
Yen C; Tate JE; Steiner CA; Cortese MM; Patel MM; Parashar UD
J Infect Dis; 2012 Jul; 206(1):41-8. PubMed ID: 22539812
[TBL] [Abstract][Full Text] [Related]
7. Intussusception and Monovalent Rotavirus Vaccination in Singapore: Self-Controlled Case Series and Risk-Benefit Study.
Yung CF; Chan SP; Soh S; Tan A; Thoon KC
J Pediatr; 2015 Jul; 167(1):163-8.e1. PubMed ID: 25882872
[TBL] [Abstract][Full Text] [Related]
8. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
[TBL] [Abstract][Full Text] [Related]
9. Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
Bruun T; Watle SSV; Tveteraas IH; Flem E
Vaccine; 2019 Sep; 37(38):5717-5723. PubMed ID: 31255303
[TBL] [Abstract][Full Text] [Related]
10. Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.
Pérez-Schael I; Escalona M; Salinas B; Materán M; Pérez ME; González G
Pediatr Infect Dis J; 2003 Mar; 22(3):234-9. PubMed ID: 12634584
[TBL] [Abstract][Full Text] [Related]
11. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
[TBL] [Abstract][Full Text] [Related]
12. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
Escolano S; Hill C; Tubert-Bitter P
Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
[TBL] [Abstract][Full Text] [Related]
13. Safety of second-generation rotavirus vaccines, intussusception.
Vázquez M
Curr Opin Pediatr; 2014 Feb; 26(1):101-5. PubMed ID: 24335963
[TBL] [Abstract][Full Text] [Related]
14. Intussusception and rotavirus vaccines: what is the background risk?
Sáez-Llorens X; Guevara JN
Pediatr Infect Dis J; 2004 Apr; 23(4):363-5. PubMed ID: 15071297
[TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction.
Linhares AC; Justino MC
Expert Rev Vaccines; 2014 Jan; 13(1):43-57. PubMed ID: 24308577
[TBL] [Abstract][Full Text] [Related]
16. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
[TBL] [Abstract][Full Text] [Related]
17. Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018.
Escolano S; Mueller JE; Tubert-Bitter P
Euro Surveill; 2020 Aug; 25(33):. PubMed ID: 32820718
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the potential risks and benefits of infant rotavirus vaccination in England.
Clark A; Jit M; Andrews N; Atchison C; Edmunds WJ; Sanderson C
Vaccine; 2014 Jun; 32(29):3604-10. PubMed ID: 24814524
[TBL] [Abstract][Full Text] [Related]
19. Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.
Yen C; Shih SM; Tate JE; Wu FT; Huang YC; Parashar UD; Hsiung CA
Pediatr Infect Dis J; 2017 Oct; 36(10):e252-e257. PubMed ID: 28640005
[TBL] [Abstract][Full Text] [Related]
20. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico.
Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T
Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
